<DOC>
	<DOCNO>NCT02100527</DOCNO>
	<brief_summary>This 6 week study characterize safety , tolerability effect PF-05175157 administer 6 week subject moderate severe acne vulgaris .</brief_summary>
	<brief_title>Study Of Safety , Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Males 18 year old diagnose moderate severe acne vulgaris otherwise healthy . Normal spirometry screening ( FEV1 FVC ( Forced Vital Capacity ) least 80 % predict ) . Minimum 20 inflammatory lesion face . Willing discontinue acne treatment prior study period followup . Subjects active nodulocystic acne . Subjects unwilling comply lifestyle guideline , commit study visit , perform study procedure . History dry eye know disease affect sclera cornea . History pulmonary disease inability adequately perform testing .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>oral dosing</keyword>
	<keyword>moderate severe acne vulgaris</keyword>
</DOC>